Skip to content
Raloxifene Tablets

Raloxifene Tablets

Raloxifene

Raloxifene 60mg film-coated tablets, used in the management of osteoporosis. A SERM that acts like oestrogen on bone but not on breast tissue.

All strengths and pack prices
StrengthPackPricePer unit
60mg10 tabletsUS$24.70US$2.47
60mg30 tabletsUS$63.00US$2.10
60mg60 tabletsUS$106.80US$1.78
60mg90 tabletsUS$153.90US$1.71
60mg120 tabletsUS$219.60US$1.83
60mg180 tabletsUS$280.80US$1.56
60mg360 tabletsUS$367.20US$1.02
Active ingredient
Raloxifene
Route
Oral use
Form
Film-coated tablet
Strengths
60mg

You will receive a quality generic, depending on stock.

No prescription needed: we place your order for Raloxifene Tablets on your behalf.

Condition
Osteoporosis
Alternative names
Evista
Therapeutic class
Selective oestrogen Receptor Modulator
Pharmacological class
SERM
Precautions and warnings
discontinue before prolonged immobilisation; monitor for signs of blood clots
Minor side effects
hot flushes; leg cramps
Moderate side effects
peripheral oedema; flu-like symptoms
Dosage forms
Film-coated tablet
Administration route
Oral use
Originator
Daiichi Sankyo
Onset time
3–6 months
Duration
Ongoing
Storage instructions
Store in a cool, dry place.
Drug interactions
warfarin; cholestyramine
Age restrictions
Limited to postmenopausal women.
Contraindications

history of venous thromboembolism; hepatic impairment; severe renal impairment; uterine bleeding; pregnancy

Serious side effects

deep vein thrombosis, requires immediate medical attention; pulmonary embolism, requires immediate medical attention; stroke, requires immediate medical attention

Patient summary

Raloxifene 60mg film-coated tablets, used in the management of osteoporosis. A SERM that acts like oestrogen on bone but not on breast tissue.

Mechanism of action

A selective oestrogen receptor modulator that mimics the beneficial effects of oestrogen on bone tissue while inhibiting its effects on breast and uterine tissue.

Pregnancy and breastfeeding

Pregnancy: Contraindicated; may cause harm to the foetus. Breastfeeding: Not applicable.

Raloxifene is the active ingredient in Raloxifene Tablets, a standard treatment option for osteoporosis. Often recognised by its primary brand name Evista, it is frequently used to support long-term bone density. Supplied by Daiichi Sankyo, these tablets are available in a 60mg strength, providing a standard form for patients maintaining bone health.

Buying Raloxifene Tablets online

Ordering online provides a reliable, convenient solution for people in Australia who require consistent access to their ongoing treatment.

What you will receive

Raloxifene Tablets is a generic medicine sold under the name of its active ingredient, Raloxifene, rather than under a brand.

  • You receive a quality generic; the exact manufacturer depends on what is in stock at the dispatching warehouse.
  • It contains the same active ingredient as the brand-name versions, at the same dose, by regulatory standard.